Xenira Pharmaceuticals is a 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 aspiring to transform the oral delivery of challenging molecules by developing scientifically proven lipid-based drug delivery systems that overcome solubility and bioavailability barriers.

Xenira is headquartered in Wrocław, Poland, and operates with a team of pharmaceutical scientists and formulation experts dedicated to enabling better therapies. Our work is powered by one mission: 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 by making promising molecules into scalable, patient-friendly oral therapies.

We believe that 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝘂𝗻𝗰𝗼𝗺𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀 are the driving forces that are essential for transforming poorly water-soluble drugs and biopharmaceuticals into commercially viable therapeutic products.

Xenira was founded by pharmaceutical development specialists to enable better oral drug delivery by combining proprietary lipid-based technologies with integrated manufacturing excellence.

We have developed a portfolio of 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀 - including nanostructured lipid carriers (NLC), solid lipid nanoparticles (SLN), liposomes, and self-emulsifying drug delivery systems (SEDDS/SNEDDS) - that are scientifically validated to enhance solubility, stability, and bioavailability of challenging active ingredients.

Our 𝗘𝗨-𝗚𝗠𝗣 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝘆 is 𝗹𝗶𝗰𝗲𝗻𝘀𝗲𝗱 𝗳𝗼𝗿 𝗰𝗼𝗻𝘁𝗿𝗼𝗹𝗹𝗲𝗱 𝘀𝘂𝗯𝘀𝘁𝗮𝗻𝗰𝗲𝘀, enabling us to support pharmaceutical partners from early formulation development through to commercial manufacturing.

Ready to explore how our delivery platforms could advance your pipeline? Connect with us to discuss partnership opportunities, technology licensing, or contract manufacturing.

📩 𝗖𝗼𝗻𝘁𝗮𝗰𝘁: 𝗰𝗼𝗻𝘁𝗮𝗰𝘁@𝘅𝗲𝗻𝗶𝗿𝗮𝗽𝗵𝗮𝗿𝗺𝗮.𝗰𝗼𝗺

XENIRA Pharmaceuticals

Org chart

Teams

Offices

XENIRA Pharmaceuticals

Org chart

Teams

Offices

Related companies